Medical Care Technologies Inc. (OTC PINK:MDCE) Announces CEO Insider Purchase of 50 Million Shares of MDCE Common Stock
Medical Care Technologies (OTC PINK:MDCE) announced that CEO Marshall Perkins purchased 50,000,000 shares of MDCE common stock on the open market at an average price of $0.0003 per share on November 19, 2025.
The purchase was made with personal funds, did not involve issuance of new company shares, and therefore did not constitute a corporate action. The company reported an unchanged outstanding share count of 3,316,305,988 common shares as of the release date.
Management said the purchase reflects alignment with shareholders and ongoing focus on transparent communications while the company pursues activities in health technology and digital wellness.
Medical Care Technologies (OTC PINK:MDCE) ha annunciato che l'amministratore delegato Marshall Perkins ha acquistato 50.000.000 azioni ordinarie MDCE sul mercato aperto a un prezzo medio di $0.0003 per azione il 19 novembre 2025.
L'acquisto è stato effettuato con fondi personali, non ha comportato l'emissione di nuove azioni della società e, pertanto, non è stata una manovra di azione societaria. La società ha comunicato un numero di azioni ordinarie in circolazione invariato pari a 3.316.305.988 azioni al momento della diffusione.
La direzione ha dichiarato che l'acquisto riflette l'allineamento con gli azionisti e l'impegno continuo per una comunicazione trasparente, mentre la società prosegue le attività nel campo della tecnologia sanitaria e del benessere digitale.
Medical Care Technologies (OTC PINK:MDCE) anunció que el CEO Marshall Perkins adquirió 50.000.000 acciones comunes de MDCE en el mercado abierto a un precio medio de $0.0003 por acción el 19 de noviembre de 2025.
La compra se realizó con fondos personales, no involucró la emisión de nuevas acciones de la empresa y, por lo tanto, no constituyó una acción corporativa. La compañía reportó un recuento de acciones en circulación sin cambios de 3.316.305.988 acciones comunes a la fecha de publicación.
La gerencia indicó que la compra refleja una alineación con los accionistas y un enfoque continuo en comunicaciones transparentes mientras la empresa persigue actividades en tecnología de la salud y bienestar digital.
Medical Care Technologies (OTC PINK:MDCE)의 CEO Marshall Perkins가 50,000,000주 MDCE 보통주를 공개 매수했고 주당 평균가가 $0.0003이며 2025년 11월 19일에 이루어졌다고 발표했습니다.
이 매수는 개인 자금으로 이루어졌으며 회사의 신규 주식 발행과는 관련이 없었고 따라서 기업 행위로 간주되지 않습니다. 발표일 현재 유통 주식 수는 3,316,305,988주로 변동이 없다고 보고되었습니다.
경영진은 이 매수가 주주들과의 정렬과 투명한 커뮤니케이션에 대한 지속적인 집중을 반영한다고 말했으며, 회사가 건강 기술 및 디지털 웰빙 분야의 활동을 계속 추구하는 동안 그렇게 밝혔습니다.
Medical Care Technologies (OTC PINK:MDCE) a annoncé que le PDG Marshall Perkins a acheté 50 000 000 actions ordinaires MDCE sur le marché libre à un prix moyen de $0,0003 par action le 19 novembre 2025.
L'achat a été effectué avec des fonds personnels, n'a pas entraîné l'émission de nouvelles actions de l'entreprise et n'a donc pas constitué une opération corporative. La société a signalé un nombre d'actions en circulation inchangé de 3 316 305 988 actions ordinaires à la date de publication.
La direction a déclaré que l'achat reflète un alignement avec les actionnaires et un engagement continu envers des communications transparentes pendant que l'entreprise poursuit des activités dans la technologie de la santé et le bien-être numérique.
Medical Care Technologies (OTC PINK:MDCE) gab bekannt, dass der CEO Marshall Perkins 50.000.000 MDCE-Stammaktien auf dem freien Markt zu einem durchschnittlichen Preis von $0,0003 pro Aktie am 19. November 2025 gekauft hat.
Der Kauf wurde mit privatem Geld getätigt, es gab keine Emission neuer Aktien des Unternehmens, und er stellte daher keine unternehmensweite Maßnahme dar. Das Unternehmen meldete eine unveränderte ausstehende Stückzahl von 3.316.305.988 Stammaktien zum Veröffentlichungsdatum.
Das Management sagte, der Kauf zeige eine Ausrichtung mit den Aktionären und den fortlaufenden Fokus auf transparente Kommunikation, während das Unternehmen Aktivitäten in Gesundheitstechnologie und digitalem Wohlbefinden verfolgt.
Medical Care Technologies (OTC PINK:MDCE) أعلنت أن المدير التنفيذي مارشال بيركنز اشترى 50,000,000 سهماً عادياً من MDCE في السوق المفتوح بسعرٍ متوسط قدره $0.000319 نوفمبر 2025.
تمت الصفقة من أموال شخصية، ولم تتضمن إصدار أسهم جديدة من الشركة، وبالتالي لم تكن إجراءً شركياً. وأفادت الشركة بأن عدد الأسهم القابلة للتداول ظل ثابتاً عند 3,316,305,988 سهماً عادياً كما في تاريخ الإصدار.
وقال المديرون إن الشراء يعكس توافقاً مع المساهمين وتركيزاً مستمراً على الشفافية في التواصل بينما تسعى الشركة لأنشطة في تكنولوجيا الصحة والرفاهية الرقمية.
- CEO purchase of 50,000,000 shares on 11/19/2025
- No new shares issued; transaction did not dilute outstanding shares
- None.
CEO's personal open-market investment reflects long-term alignment with shareholders and continued commitment to transparency, excellence and innovation.
MESA, ARIZONA / ACCESS Newswire / November 20, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) (the "Company") today announced that its Chief Executive Officer, Marshall Perkins, purchased 50,000,000 shares of MDCE common stock on the open market at an average purchase price of
The shares were purchased using personal funds and reflect a personal investment by Mr. Perkins. No new shares were issued by the Company in connection with this transaction, and therefore it does not constitute a corporate action.
As of the date of this release, the Company's outstanding share count remains 3,316,305,988 shares of common stock.
"This purchase represents my personal investment decision and continued confidence in the Company's business direction," said Marshall Perkins, Chief Executive Officer of Medical Care Technologies Inc. "We remain focused on maintaining transparent communication and operational progress for our shareholders."
The Company continues to pursue its business activities in the health technology and digital wellness sector and will provide updates through OTC Markets disclosures as developments warrant.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC Pink: MDCE) is a development-stage health technology company focused on integrating artificial intelligence into consumer-facing health and wellness applications. The Company operates under the Alternative Reporting Standard and provides regular updates through its OTC Markets profile at www.otcmarkets.com/stock/MDCE.
For more information, please visit www.medicalcaretechnologies.com.
Contact Information
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221
Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: info@infiniteauctions.com
Website: www.mdcestock.com
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could cause such differences include general economic conditions, changes in market demand, competitive factors, and regulatory developments. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
What did MDCE announce about insider purchases on November 20, 2025?
Did the MDCE insider purchase involve new shares or company issuance?
How many MDCE shares were outstanding after the CEO purchase?
When did Marshall Perkins purchase MDCE shares and at what price?
What does the MDCE release say about the purpose of the CEO purchase?
Where will MDCE provide future updates about business developments?
